This brand name is authorized in Poland.
The drug HALIDOR contains one active pharmaceutical ingredient (API):
1
|
UNII
OZN2MG334O - BENCYCLANE FUMARATE
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C04AX11 | Bencyclane | C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AX Other peripheral vasodilators |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| PL | Rejestru Produktów Leczniczych | 100028165, 100434540, 100434669, 100444515 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.